Bluejay Diagnostics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $20.4M | $19.0M |
| FY2022 | — | $11.5M | $10.1M |
| FY2023 | — | $2.9M | $2.2M |
| FY2024 | — | $5.7M | $4.3M |
| FY2025 | — | $6.0M | $5.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $20.4M | $19.0M |
| FY2022 | — | $11.5M | $10.1M |
| FY2023 | — | $2.9M | $2.2M |
| FY2024 | — | $5.7M | $4.3M |
| FY2025 | — | $6.0M | $5.2M |